Enveda Biosciences Inc., a biotechnology company that leverages artificial intelligence to develop new medicines, announced today that it has raised $130 million in new funding to deliver clinical ...

Researchers at Purdue University have developed an AI platform that accelerates scientific and drug discovery in an an AI-powered lab. In Gaurav Chopra’s lab, discovery starts with a conversation with ...

Seattle biotech startup Rhizome Research has emerged from stealth with technology for creating small-molecule drug candidates ...

Slumbering among thousands of bacterial strains in a collection of natural specimens at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, several fragile vials held ...

Google DeepMind has unexpectedly released the source code and model weights of AlphaFold 3 for academic use, marking a significant advance that could accelerate scientific discovery and drug ...

If you asked an AI to generate a brand-new drug discovery biotech with a team of some of the biggest names in the biz for you, it couldn’t dream up one like Xaira Therapeutics. The company emerged ...

A genetic mutation passed from mother to children in families affected by schizophrenia has now been shown to completely ...

In the pharmaceutical discovery process, understanding a drug’s residence time—the duration a molecule remains bound to its ...

(SALT LAKE CITY)—One of the big hurdles in bringing drugs to market is the difficulty of producing large enough quantities of potential compounds to conduct clinical trials. This is particularly true ...

A version of this story appeared in Volume 101, Issue 36 Not too long ago, these small-molecule drugs looked as if they were going out of fashion. Advances in biotechnology enabled pharmaceutical ...